Patent details

Basic Information

Publication number:

EP3110454

PCT Application Number:

US2015017302

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP157528035

PCT Publication Number:

WO2015127439

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION

French Title of Invention:

MÉTHODES ET COMPOSITIONS POUR L'INTÉGRATION CIBLÉE MÉDIÉE PAR LES NUCLÉASES

German Title of Invention:

VERFAHREN UND ZUSAMMENSETZUNGEN ZUR NUKLEASEVERMITTELTEN GEZIELTEN INTEGRATION

SPC Number:

Dates

Filing date:

24/02/2015

Grant date:

18/11/2020

EP Publication Date:

04/01/2017

PCT Publication Date:

27/08/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/11/2020

EP B1 Publication Date:

18/11/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

24/02/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/11/2020

 

 

Name:

Sangamo Therapeutics, Inc.

Address:

501 Canal Blvd. Suite A100, Richmond, CA 94804, United States (US)

Inventor

1

Name:

WECHSLER, Thomas

Address:

United States (US)

2

Name:

HOLMES, Michael C.

Address:

United States (US)

Priority

Priority Number:

201461943865 P

Priority Date:

24/02/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 48/00; C12N 5/10; C12N 15/64;

Publication

European Patent Bulletin

Issue number:

202047

Publication date:

18/11/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/08/2021

Annual Fee Number:

7

Annual Fee Amount:

82 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages